Nurix 治療公司
US ˙ NasdaqGM ˙ US67080M1036

簡介

本頁面提供了有關 Houte Hans van 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Houte Hans van已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:NRIX / Nurix Therapeutics, Inc. Chief Financial Officer 37,592
如何解讀這些圖表

以下圖表顯示了在Houte Hans van進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

NRIX / Nurix Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 NRIX / Nurix Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

NRIX / Nurix Therapeutics, Inc. Insider Trades
NRIX / Nurix Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 NRIX / Nurix Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2026-04-30 NRIX van Houte Hans 2,388 16.6453 2,388 16.6453 39,749 36 14.6400 -4,788 -12.05
2026-01-30 NRIX van Houte Hans 3,588 16.5826 3,588 16.5826 59,498
2026-01-30 NRIX van Houte Hans 73 17.3717 73 17.3717 1,268
2025-10-30 NRIX van Houte Hans 3,130 12.7967 3,130 12.7967 40,054
2025-07-30 NRIX van Houte Hans 4,304 12.0110 4,304 12.0110 51,695
2025-04-30 NRIX van Houte Hans 2,438 11.5017 2,438 11.5017 28,041
2025-01-30 NRIX van Houte Hans 2,557 19.8068 2,557 19.8068 50,646
2025-01-30 NRIX van Houte Hans 254 20.3256 254 20.3256 5,163
2024-10-30 NRIX van Houte Hans 2,368 24.3050 2,368 24.3050 57,554
2024-07-30 NRIX van Houte Hans 2,490 20.6677 2,490 20.6677 51,463
2024-04-30 NRIX van Houte Hans 1,387 12.0422 1,387 12.0422 16,703
2024-01-30 NRIX van Houte Hans 1,671 7.9902 1,671 7.9902 13,352
2023-10-31 NRIX van Houte Hans 1,080 5.1974 1,080 5.1974 5,613
2023-07-31 NRIX van Houte Hans 1,245 9.6547 1,245 9.6547 12,020
2023-05-01 NRIX van Houte Hans 721 9.8763 721 9.8763 7,121
2023-01-30 NRIX van Houte Hans 924 11.7796 924 11.7796 10,884
2022-10-31 NRIX van Houte Hans 739 12.8805 739 12.8805 9,519
2022-08-01 NRIX van Houte Hans 752 15.6700 752 15.6700 11,784
2022-05-02 NRIX van Houte Hans 697 11.7500 697 11.7500 8,190

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

NRIX / Nurix Therapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Houte Hans van 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-05 2026-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -582 37,592 -1.52 17.18 -9,996 645,646
2026-05-05 2026-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -13,473 38,174 -26.09 16.58 -223,323 632,757
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2,388 51,647 -4.42 16.65 -39,749 859,680
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,858 54,035 5.58
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 51,177 7.91
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 47,427 4.40
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -73 45,427 -0.16 17.37 -1,268 789,144
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -3,588 45,500 -7.31 16.58 -59,498 754,508
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,859 49,088 6.18
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 46,229 8.83
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 42,479 4.94
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,887 40,479 7.68
2025-11-03 2025-11-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -6,284 37,592 -14.32 12.56 -78,931 472,182
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -3,130 43,876 -6.66 12.80 -40,054 561,468
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,858 47,006 6.47
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 44,148 9.28
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 40,398 5.21
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 38,398 8.13
2025-08-01 2025-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5,402 35,512 -13.20 11.03 -59,598 391,786
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -4,304 40,914 -9.52 12.01 -51,695 491,418
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,858 45,218 6.75
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 42,360 9.71
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 38,610 5.46
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 36,610 8.56
2025-05-02 2025-05-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -6,198 33,724 -15.53 11.33 -70,243 382,197
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2,438 39,922 -5.76 11.50 -28,041 459,171
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 42,360 9.71
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 38,610 5.46
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 36,610 8.56
2025-03-03 2025-03-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -700 33,724 -2.03 15.13 -10,591 510,234
2025-03-03 2025-03-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5,125 34,424 -12.96 14.40 -73,797 495,685
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -254 39,549 -0.64 20.33 -5,163 803,857
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2,557 39,803 -6.04 19.81 -50,646 788,370
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 42,360 9.71
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 38,610 5.46
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 36,610 8.56
2024-11-01 2024-11-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3,546 33,724 -9.51 24.28 -86,083 818,691
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2,368 37,270 -5.97 24.30 -57,554 905,847
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 39,638 10.45
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 35,888 5.90
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 33,888 9.31
2024-08-26 2024-08-26 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -20,000 31,002 -39.21 25.22 -504,370 781,824
2024-08-01 2024-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -100 51,002 -0.20 22.22 -2,222 1,133,264
2024-08-01 2024-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3,377 51,102 -6.20 21.43 -72,354 1,094,886
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2,490 54,479 -4.37 20.67 -51,463 1,125,956
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3,750 56,969 7.05
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 53,219 3.90
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 51,219 5.97
2024-06-20 2024-06-20 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -20,000 48,333 -29.27 20.01 -400,216 967,182
2024-05-02 2024-05-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3,499 68,333 -4.87 12.83 -44,878 876,439
2024-04-30 2024-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1,387 71,832 -1.89 12.04 -16,703 865,015
2024-04-30 2024-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 73,219 2.81
2024-04-30 2024-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 71,219 4.22
2024-02-16 2024-02-16 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -6,812 68,333 -9.07 10.02 -68,223 684,362
2024-01-30 2024-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1,671 75,145 -2.18 7.99 -13,352 600,424
2024-01-30 2024-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 76,816 2.67
2024-01-30 2024-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 74,816 4.01
2023-12-21 2023-12-20 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3,541 71,930 -4.69 10.00 -35,421 719,523
2023-12-20 2023-12-19 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -10,906 75,471 -12.63 10.00 -109,093 754,936
2023-11-01 2023-10-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1,080 86,377 -1.23 5.20 -5,613 448,936
2023-11-01 2023-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 87,457 2.34
2023-11-01 2023-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 85,457 3.50
2023-08-01 2023-07-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1,245 82,571 -1.49 9.65 -12,020 797,198
2023-08-01 2023-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,000 83,816 2.44
2023-08-01 2023-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 81,816 3.66
2023-05-02 2023-05-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -721 78,930 -0.91 9.88 -7,121 779,536
2023-05-02 2023-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 79,651 3.76
2023-02-01 2023-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -924 76,765 -1.19 11.78 -10,884 904,261
2023-02-01 2023-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 77,689 3.86
2022-11-01 2022-10-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -739 74,803 -0.98 12.88 -9,519 963,500
2022-11-01 2022-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 75,542 3.97
2022-08-02 2022-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -752 72,656 -1.02 15.67 -11,784 1,138,520
2022-08-02 2022-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 73,408 4.09
2022-06-01 2022-05-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 68,333 70,522 3,121.65 0.84 57,400 59,238
2022-05-03 2022-05-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -697 2,189 -24.15 11.75 -8,190 25,721
2022-05-03 2022-04-30 4 NRIX Nurix Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,886 43,291 -6.25
2022-05-03 2022-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2,886 2,886
2022-01-21 2022-01-19 4 NRIX Nurix Therapeutics, Inc.
Restricted Stock Units
A - Award 46,177 46,177
2022-01-21 2022-01-19 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 103,894 103,894
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,829 36,504 -4.77
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -13,197 20,136 -39.59
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -20,393 9,027 -69.32
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -35,419 0 -100.00 39.90 -1,413,218
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1,829 35,419 5.45 7.26 13,279 257,142
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 13,197 33,590 64.71 1.86 24,546 62,477
2021-02-25 2021-02-24 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 20,393 20,393 1.20 24,472 24,472
2021-02-23 2021-02-22 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -3,913 29,420 -11.74
2021-02-23 2021-02-22 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,417 68,333 -2.03
2021-02-23 2021-02-22 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5,330 0 -100.00 39.93 -212,839
2021-02-23 2021-02-22 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3,913 5,330 276.15 1.20 4,696 6,396
2021-02-23 2021-02-22 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1,417 1,417 0.84 1,190 1,190
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -13,583 69,750 -16.30
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -400 0 -100.00 38.05 -15,219
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -666 400 -62.48 36.91 -24,581 14,764
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5,725 1,066 -84.30 36.00 -206,109 38,378
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3,652 6,791 -34.97 35.10 -128,201 238,393
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3,140 10,443 -23.12 34.24 -107,511 357,560
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 13,583 13,583 0.84 11,410 11,410
2021-02-12 2021-02-11 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 40,000 40,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)